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A B S T R A C T 
Serum albumin is the major constituent (30-407=) of 
total serum proteins in mammals. It binds with numerous 
structurally different compounds, such as bilirubin, fatty 
acids, various drugs and some inorganic ions. The bilirubin 
binding to bovine and human albumins has been extensively 
studied but still the amino acids involved and mechanism of 
binding is not clear. In this dissertation, I have studied 
this interaction using three different albumins namely 
sheep, bovine and human. HSA and SSA were isolated from 
respective blood samples by a modified salt fractionation 
procedure developed in this laboratory. The isolated HSA 
and SSA were fairly homogeneous as judged by PAGE and by gel 
filteration on Sephacryl S-300. The three preparations 
namely the isolated HSA and SSA and the commercial BSA were 
identical within experimental error in- their relative 
mobility in PAGE and in their Ve/Vo ratio on Sephacryl 
S-300. 
The interaction of bilirubin with the three albumins 
was studied at different ionic strengths and pH values by 
visible spectroscopy and by fluorescence quenching 
technique. The three albumin preparations were very 
similar in their bilirubin binding characteristics as 
revealed by visible light absorption spectra tsk their 
XI. 
complexes with bilirubin. The fluorescence quenching 
curves of three albumins upon addition of bilirubin were 
very similar. The effect of ionic strength in bilirubin 
albumin interaction clearly suggested the role of 
electrostatic effect in this interaction. The binding of 
bilirubin to albumin decrease-S with increase in ionic 
strength. This effect, however, was less pronounced in HSA 
than in BSA and SSA. The pH has no effect on bilirubin 
binding upto about pH 11.0. Above pH 11.0 bilirubin 
binding decreases sharply presumably because of alkali 
induced structural changes in the protein. This result 
again emphasizes that if a positively charged lysine side 
chain is involved in this interaction than it should have an 
abnormally high pK (>11.0). The similarity of results of 
SSA with those of BSA and HSA suggest that the binding 
mechanism in the three albumin is very similar. 
13.1 
A C K N O W L E D G E M E N T 
I have great pleasure in expressing my deep sense of 
gratitude to my esteemed supervisor, Dr. M. Abul Qasim for 
his able guidence and help throughout the course of this 
work. His valuable advice has been a constant source of 
encouragement and inspiration. 
I acknowledge my gratitude to Prof. A. Salahuddin, 
Chairman of the department for providing me all the 
necessary facilities. I feel obliged to Prof. Rashid Ali 
Ex-Chairman for his kind and affectionate advise and 
constant encouragement. 
My sincere thanks are due to Prof. S.M. Hadi 
Chairman, Department of Biochemistry F/0 Life Sciences and 
Prof. M. Shafiulla Department of Chemistry for their 
genuine help and guidance. 
I am also grateful to Dr. M.U. Siddiqui, 
Dr. Asif Ali, Dr. (Mrs.) Khushtar Anwar, Dr. A.F. Faizy, 
Dr. Enamul Haque for their valuable suggestions. 
My gratitude is due to my teachers Dr.Imrana Naseem 
Department of Biochemistry, F/0 Life Science, Dr. Saad 
Tayyab and Dr. Javed Musarrat, Interdisciplinary 
Biotechnology unit for their help and encouragement. 
IV 
My sincere thanks are due to my senior colleagues, 
Dr. Najmul Islam, Dr. Naushad Ali, Mrs. Vandana Sehgal, 
Mr. Khursheed Alam, Mrs. Zoya, Miss Jahan Ara and 
Miss Zarina Arif for their incessant help. 
I put warm and heartiest thanks to my collegues 
Mr. Nisar Ahmad, Mr. V.D. Trivedi and Miss Indu Saxena for 
their timely suggestions and discussion which helped a lot 
in this work. 
I gratefully acknowledge the help extended by 
Mr. Moinuddin & Sadia Arjumand. I also appreciate the help 
extended by Mr. Rizwan Ahmed and Mr. Ashfaq Ali. 
There are few who hold a special place in my life 
and command a mention in this acknowledgement are 
Mrs. & Mr. (Dr) Abdul Qayyum Khan, Dr. Ahsan Ayub Khan, 
Mr. Khalid Ameer Khan, Mr. Mohannad Jazzar and 
Mr. Saeed Ahmad. 
My special thanks to my brothers Anwar, Tarique, 
Jamal and Abddul Mannan for their love during this study. 
I would like to express my thanks to staff members of 
M/S Competent Xerox Centre, Champion Market, Aligarh for 
giving final shape to my work. 
Above all, I shall forever remain Indebted to my 
parents and sisters for their love, affection, support and 
confidence they have reposed in me. 
MD. NAJMUDDIN KHAN 
vi 
LIST OF TABLES 
Page No, 
Table I: Physicochemical properties of bovine 
and human serum albumins 3 
Table II: Binding of some ligands to albumin 6 
Table III:List of Chemicals 12 
Table IV; Gel filteration, electrophoretic and 
fluorescence data for serum 
albumins 27 
Table V: Comparative bilirubinrbinding data of serum 
albumins at different molar ratios 37 
Table VI: Comparative bilirubin, binding data of serum 
albumins at different ionic strengths 43 
Table VII :Comparative fluorescence quenching 
data of BSA, HSA and SSA 54 
V l l . 
LIST OF FIGURES 
Page No 
Fig. ,1 Primary structure of 
human serum albumin 4 
Fig. 2 Elution profiles of HSA and SSA on 
Sephacryl S-300 column 25 
Fig. 3 Elution profile of BSA on Sephacryl 
S-300 column 26 
Fig. 4 Polyacrylamide gel electrophoretic 
pattern of BSA, HSA and SSA 29 
Fig. 5 Fluorescence excitation spectra of 
BSA, HSA and SSA ^0 
Fig. 6 Fluorescence emission spectra of 
BSA, HSA and SSA 31 
Fig. 7 Absorption spectra of bilirubin in 
absence and presence of albumins 32 
Fig. 8 Visible difference absorption spectra 
of bilirubin-BSA complex at different 
molar ratios 34 
Fig. 9 Visible difference absorption sepctra 
of bilirubin-HSA complex at different 
molar ratios 35 
Vlll 
Page No 
Fig. 10 Visible difference absorption spectra 
of bilirubin-SSA complex at different 
molar ratios 
Fig. 11 Visible difference absorption spectra 
of bilirubin-BSA complex at different 
ionic strengths 
Fig. 12 Visible difference absorption spectra 
of bilirubin-HSA complex at different 
ionic strengths 
Fig. 13 Visible difference absorption spectra 
of bilirubin-SSA complex at different 
ionic strengths 
Fig. 14 Plot of AOD-'-'^" ,Qn of bilirubin-
° 480nm 
albumin complexes as a functionAionic 
strengths 
Fig. 15 Amino acid sequence (210-240) of 
primary bilirubin binding site of 
HSA and BSA 
Fig. 16 Visible difference absorption spectra 
of bilirubin-BSA complex at different 
pH values 
Fig. 17 Visible difference absorption 
spectra of bilirubin-HSA complex at 
different pH values 
36 
38 
39 
40 
41 
44 
45 
46 
IX 
Page No, 
Fig. 18 Visible difference absorption spectra 
of bilirubin-SSA complex at different 
pH values 47 
Fig. 19 Plot of O^D-'-^ °^ gQ ^^ of bilirubin-
albumin complexes as a function of 
pH values 48 
Fig. 20 Emission spectra of albumins in 
absence and presence of bilirubin 50 
Fir. 21 Plot of percent quenching of BSA as 
a function of B/A ratio 51 
Fig. 22 Plot of percent quenching of HSA as 
a function of B/A ratio 52 
Fig. 23 Plot of percent quenching of SSA 
as a function of B/A ratio 53 
I N T R O D U C T I O N 
INTRODUCTION 
Serum albumin is the most abundant protein in the 
sera of higher animals. In mamals it constitutes about 
30-40 percent of the total amount of serum proteins. 
A wide variety of functions have been attributed to 
serum albumin. Many of the important functions depend 
on the remarkable capacity of serum albumin to bind with 
structurally diverse compounds. Virtually any small 
molecular weight compound which enters blood circulation 
binds weakly or strongly with albumin. In several cases the 
physiological importance of this interaction has been 
explained. 
Serum albumin from human and bovine has been studied 
extensively with respect to its structure and function 
(Peters, 1970, 1975, 1985). A number of workers have also 
used human and bovine serum albumins as model proteins. 
Described below is a brief outline of the relevant 
structural and functional information available on serum 
albumins. The description given below pertains to the 
information available on human and bovine serum albumin. 
Physicochcniical Properties: 
Serum albumins are highly water soluble. In serum 
they occur at a concentration 35 mg/ml but in vitro 
experiments much more highly concentrated solutions are 
possible. Molecular weight has been determined by a number 
of techniques to be in the range of 65,000-69,000. (Baldwin, 
1957; Squire et al, 1968; Tanford, 1968). This range is in 
very good agreement with molecular weight calculated 
(calculated MW 66,439) from amino acid composition (Brown 
and Shockley, 1982). Albumin molecule resembles with many 
other globular proteins in its hydrodynamic properties. It 
behaves like a prolate ellipsoid of revolution with 
dimensions of 41.6 x 140.9A° (Wright and Thompson, 1957). 
This would give an axial ratio of 3.4. This behaviour is 
consistent with the presence of three structural domains in 
albumin molecule which are arranged in a linear fashion like 
three tennis balls in a cylindrical can (Anderson and Weber, 
1969). 
Serum albumins are acidic proteins with isoelectric 
point ocuring at pH 4.7.. Some of the physicochemical 
properties are listed in Table 1. 
Structure: 
Human and bovine serum albumins contain 584 and 582 
amino acids respectively present in a single polypeptide 
chain. The primary structure of bovine and human serum 
albumin have been determined by Brown and coworkers (Brown 
1975; Meloun et al 1975). The primary structure of human 
serum albumin is shown in Pig. 1. The serum albumin 
molecule is organized in three structural domains of nearly 
Table I 
Physicochemical properties of BSA and HSA 
Property 
Molecular wei-
ght from comp-
osition 
from Physical 
data 
Intrinsic 
Viscosity-n _H 
g. decilitre 
Overal 41 
dimensions 
°A 
Specific 
extinction 
coefficient 
Isoelectric 
Point 
Bovine 
66,430 
66,700 
0.041 
.6x140.9 
6.67 
4.7 
Reference 
Squire et 
al (1968) 
Mc Millan 
(1974) 
Wright and 
Thompson 
(1975)' 
Janatova et a 
(1968) 
Peters 
(1975) 
Human 
66,439 
69,000 
0.042 
38x 150 
1 5.31 
Reference 
Charlwood 
(1961) 
ChaiIwood 
(1961) 
Hughes (19 
Edward et ; 
(1969). 
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equal size (domain I, residues 1-190, domain II, residue 
191-382, domain III, residue 383-582). There is about 207o 
sequence homology between these three domains. Each domain 
is further divided into two large and one small double loop. 
Except the first large double loop in domian I all the other 
large and small loops are held together by disulfide bonds. 
The protein contains 17 disulfide bonds and one cysteine 
residue. All the disulfide bonds are intradomian disulfide 
bonds. 
Secondary structure analysis gives high helical 
content in serum albumins. The K^^ helix calculated from 
circular dichroism studies comes out to be about 557o. The 
protein also contains about 16 percent p structure. Except 
at around the bend position majority of the amino acid 
residues in the large and small double loops are present in 
o^-helix conformation. The tertiary structure within a domain 
is formed by the spatial arrangement of large and small 
loops to form a somewhat cylindrical structure containing a 
distinct hydrophobic and a hydrophilic region. 
Ligand binding properties: 
Albumin binds a variety of different compounds 
differing in structure and properties {Peters, 1970. 1975). 
Some of these compounds are listed in Table II. Binding 
of these compounds may be important for a variety of 
reasons, such as: (i) preventing their removal from blood 
Table II 
Binding of some ligands to Albumins 
Compound Association constant Reference 
Oleate 
Stearate 
Linoleate 
Palni'itate 
Lithocholate 
Cortesol 
Bilirubin 
Hematin 
L-Tryptophan 
L-Thyroxine 
26 X 10' 
15.0 X 10' 
7.9 X 10' 
6.2 X 10' 
9 X 10' 
5 X 10-
Specterand Fletcher 
(1978) 
5 X 10' 
1.1 X 10 
6.2 X 10' 
1.6 X 10^ 
8 
Roda et al (1982) 
Yates and Urquhert 
(1962) 
Jacobsen (1977) 
Adams and Bermann 
(1980) 
Sollene et al (1981) 
Steiner et al (1968) 
circulation into urine 
ii) making them intoxic or 
iii) making poorly soluble compounds soluble in the 
aqueous medium. 
Many of the organic compounds which bind to albumin 
are anionic in character. These include bilirubin, fatty 
acids and a number of drugs. Electrostatic interaction is one 
of the important noncovalent interaction which is involved 
in binding of these compounds. The binding of bilirubin and 
fatty acids has been studied in detail (Broderson, 1974, 
Brodersen and Ebbesen, 1983). Some of the drugs which bind 
with albumin are ampicillin, warfarin, diazepam, digi toxin, 
salicylic acid etc. (Broderson et al , 1988). Many organic 
dyes like methyl red (Burkhard et al, 1961) phenolred 
(Rodkey, 1961), bromocresol green (Rcdkey, 1961), 
bromophenol blue (Bjerrum, 1968), Congored (Peters 1970) 
etc. also bind to serum albumin. Other biologically important 
compounds interacting with albumin are tryptophan,.. (Fuller 
and Roush, 1973; Cannighara et al , 1975) thyroxine, cortesol 
etc. Albumin also binds to cibacron blue (Ghiggeri and 
Queirola, 1985). This interaction has been exploited in the isolation 
and purification of serum albumin by affinity chromatography 
on cibacron blue Sepharose column. 
On the basis of several interaction studies it is 
proposed by Sjoholm et al , (1979) that albumin contains 
8 
three permanent binding sites. The binding sites of fatty 
acids and bilirubin are the most studied sites because both 
of these ligands are physiologically important and are 
transported in the blood in the form of complexes with 
albumin. Circulating albumin carries O-'-S-Z.O mole of fatty 
4 
acids per mole of albumin, although in vitro albumin has 
been demonstrated to be capable of binding as many as 6 mol 
of stearate, 7 mol of palmitate, and 8 mol of oleate 
(Spector, 1965). It is believed that albumin molecule 
contains fatty acid binding sites of descreasing affinity. 
The first two fatty acids bind in an antiparallel fashion in 
domain III of HSA. Recent studies with BSA using affinity 
labelling and nuclear magnetic resonance spectroscopy (Read 
1986. Cistola et al, 1987) have established the presence of 
two strong binding sites in COOH terminal half of albumin 
and a somewhat weaker site in the NH^ terminal half. 
Bilirubin-Albumin binding: 
The interaction of bilirubin was studied with 
various proteolytic fragments of BSA in order to localize 
the binding site of bilirubin on albumin. Out of twelve fragments only 
three P- B (1-306), P-44 (1-385) and P-14 (186-306) were^ 
able to interact with bilirubin (Reed et al, 1975). It was 
proposed that primary bilirubin binding site lies closeto 
the N-terminal of domain II because 186-238 sequence is 
common in all the three fragments which bind with bilirubin. 
There are two relatively wea ker binding sites (Ka = 5xlO^M ''-) 
(Jacobsen, 1969). Under physiological condition the primary 
binding site is not saturated because of low concentration of 
bilirubin but in jaundiced -^neonates the primary binding site 
Is saturated and the bilirubin enter: into central nervous 
system causing kernicterus (Broderson, 1979 a). Thus it 
appeared that second and third binding site play, If any 
insignificant role In detoxification of bilirubin. 
The role of amino acids in bilirubin binding was 
investigated by several chemical modification studies. It 
was proposed by Jacobsen (1972) that arglnine, hlstldlne and 
ty.TOslne may be important In this Interaction at the primary 
binding site. Later Jacobsen (1976) showed the Involvement 
of lysine residues in this interaction. A novel approach of 
covalent coupling of bilirubin to primary binding site was 
used by Jacobsen (1978) to couple reactive lysine with 
bilirubin. On the basis of his results Jacobsen proposed lys 
240 in HSA and (lys 238 in BSA) to be the critical lysine 
residue. Despite of general recognition of Jacobsen's work 
there is some disagreement about the position of reactive 
lysine residue. Thus some other workers have proposed lysine 
220 and lys 195 to be the reactive lysine residue. 
Mechanistic studies of bilirubin binding have been 
very few. The most Important of these are reported by 
Jacobsen and Brodersen (1983). From their study, it appeared 
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that bilirubin binding is biphasic. A fast phase which takes 
place in milliseconds and a slow phase which involves a 
series of relaxational changes in albumin molecules. 
In this dissertation interaction of bilirubin with a 
hitherto uninvestigated protein namely sheep serum albumin 
is studied and the results are compared with the interaction 
of bilirubin with human and bovine serum albumin. 
E X P E R I M E N T A L S 
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CHEMICAL AND METHODS 
The chemicals used in this study are listed in 
Table-Ill. 
1. pH measurements: Elico pH meter model Ll-IOT using 
Elico combined glass electrode type CL51, was used for the 
pH measurements. The least count of pH meter was 0.05 pH 
unit. The pH meter was calibrated before pH measurements. 
The standard buffer of pH 4.0, 7.0 and 9.2 were used for the 
calibration of the pH meter in acidic, neutral and alkaline 
pH range respectively. 
2. Optical measurements: A Shimadzu double beam 
spectrophotometer, model UV-150-02, was used for the 
measurements of light absorption in visible as well as in 
ultraviolet region. The matched silica cells of 1.0 cm path 
length were used. Fluorescence measurements were performed 
on a Shimadzu spectrofluorometer, model RF-540, equipped 
with a data recorder, model DR - 3. 
3. Determination of protein concentration: The protein 
concentration was determined by one of the two following 
methods: 
i) UV method 
ii) Method of Lowry et al (1951) 
TABLE - III 
LIST OF CHEMICALS 
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S .No. Chemi cals Source 
1 2 3 
1. Acetic acid Glaxo Laboratories, India 
2. Acrylaraide Sisco Research Lab.,India 
3. Amido Schwarz E. Merck, Germany 
4. Ammonium per sulphate Sisco Research Lab., India 
5. Ammonium sulphate Sarabhai M. Chemicals, India 
6. Bilirubin Sigma Chemicals Co., USA 
7. Blue dextran V.P. Chest Institute, India 
8. Bromophenol blue PPH Polskie, Poland 
9. Bovine Serum albumin Sisco Chemicals Lab., India 
10. Bromine E. Merck, India 
11. Buffer tablets (pH, 4.0, Glaxo Laboratories, India 
pH 7.0, pH 9.2) 
12. Chloroform Glaxo Laboratories, India 
13. Copper Sulphate Glaxo Laboratories, India 
14. Dialysis sacks Sigma Chemical Co. USA 
15. Ethylene diamine tetra BDH, India 
acetic disodiura salt 
16. Lithium sulphate Glaxo Laboratories, India 
17. Methanol Glaxo Laboratories, India 
18. Millipore filter Millipore Corporation, USA 
19. N,N' Methylene bis Reanal, Hungary 
acrylamide 
20. N,N,N',N' Tetra methyl BDH, Poole, England 
ethylene diamine (TEMED) 
21. Orthophosphoric acid Glaxo Laboratories, India 
22. Potassium dichromate Glaxo Laboratories, India 
23. Potassium permanganate BDH, India 
13 
24. Riboflavin E,Merck, Germany 
25. Sephadex G-200 Pharmacia Fine Chemicals, Sweden 
26. Sephacryl S-300 Sigma Chemicals Co. USA 
27. Sodium Acetate Pfizer Ltd., India 
28. Sodium azide Fischer Scientific Company, USA 
29. Sodium bicarbonate Sarabhai M. Chemicals, India 
30. Sodium Carbonate Sarabhai M. Chemicals, India 
31. Sodium dodecyl sulphate BDH Chemical Ltd., England 
32. Sodium hydroxide Glaxo Laboratories, India 
33. Sodium molybdate Burgoygne& Co. L India 
34. Sodium phosphate Sarabbai M. Chemicals, India 
(Dibasic) 
35. Sodium phosphate Sarabhai M. Chemicals, India 
(Monobasic) 
36. Sodium potassium Glaxo Laboratories, Idnia 
tartarate 
37. Sodium tungstate Glaxo Laboratories, India 
38. Sucrose Glaxo Laboratories, India 
39. Sulphuric acid Glaxo Laboratories, India 
40. Toluene Pfizer Ltd., India 
41. Tris (hydroxy, methyl Spectrochem, Pvt. Ltd., India 
amino methane) 
42. Whatman filter paper Whatman Ltd., England 
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i) Determination of protein concentration by UV method: 
Protein concentration in a given solution containing 
appropriate amount of protein was determined by reading 
absorbance at the ^  max (278-280 nm) of the protein using 
buffer or distilled water as blank. Protein concentration 
determination by UV method was restricted to the protein 
concentration determination in BSA and HSA by using 
extinction coefficient values. Values of extinction 
coefficient at 279 nm for these two proteins were taken to 
be 6.67 and 5.31 (Janatova et al, 1968; Edwards et al. , 
1969) respectively. 
ii) Method of Lowry et al. (1951): Two reagents were used 
in this method: 
i) Copper reagent 
ii) Folin-Phenol reagent 
i) Preparation of copper reagent: 
For the preparation of copper reagent the following 
three stock solutions were used: 
i) 47o sodium carbonate (W/V) 
ii) 47o potassium tartarate (W/V) 
iii) 27o copper sulphate (W/V) 
Solutions (i), (ii) and (iii) were mixed in a ratio of 100: 
1:1 to obtain the copper reagent. The solution was filtered 
before use. 
15 
ii) Preparation of Folin-Phenol reagent: 
This reagent was prepared according to the procedure 
given by Folin and Ciocalteu (1927). One hundred grams of 
sodium tungstate, twenty five grams of sodium molybdate, 
fifty millilitre of 85% orthophosphoric acid, one hundred 
millilitre of hydrochloric acid and seven hundred millilitre 
of distilled water were mixed in a two litre round bottom 
flask, wrapped with black carbon paper to protect it from 
light. The flask was shaken thoroughly, fitted with a double 
walled glass condenser and then the contents were refluxed 
for about ten hours. One hundred fifty gram lithium 
sulphate, fifty millilitre distilled water and a few drops 
of liquid bromine were added in refluxed mixture and boiled 
for thirty minutes without condenser to remove excess 
bromine. The total volume of mixture was made upto one litre 
with distilled water after cooling. The Folin-Phenol reagent 
thus prepared was stored in an amber coloured bottle. 
The reagent was diluted with distilled water in a 
ratio of 1:4 (V/V) just before use. 
Procedure: 
An appropriate volume of a protein solution was taken 
in test tubes and the total volume was made upto one 
millilitre with addition of buffer or distilled water. Five 
millilitre of freshly prepared copper reagent was added to 
the protein solution, mixed well and after ten minutes one 
millilitre of diluted Folin-Phenol reagent was added and the 
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contents were mixed well. The colour intensity was recorded 
at 700 nm after half an hour on a double beam 
spectrophotometer using a blank solution which contained 
1.0 millilitre buffer or distilled water instead of 
protein solution. 
Isolation of Human and Sheep serum albumin: 
In a conical flask one hundred millilitre of human 
(or sheep) serum and 141.0 millilitre of 4.0 M ammonium 
sulphate solution (whose pH had been adjusted to 7.0 with 
ammonium, hydroxide) were taken to make the serum 2.26 M in 
ammonium sulphate. The mixture was kept for twelve hours at 
room temperature and then centrifuged at 7000 rpm for twenty 
minutes. Precipitate was discarded and the supernatant was 
carefully diluted with water with frequent additions of 0.5 
N sulphuric acid to make the final concentration of ammonium 
sulphate solution to 1.9 M and pH 4.2. The mixture was 
incubated for twelve hours at room temperature and the 
precipitate was collected by centrifugation at 7000 rpm for 
twenty minutes. The precipitate was washed three times with 
2.2 M ammonium sulphate solutions pH 4.2 and then dissolved 
in 0.06 M sodium phosphate buffer, pH 7.0. Dialysis was done 
against 0.06 M Sodium phosphate buffer. 
The serum albumin thus obtained was further purified 
by column chromatography on sephadex G-200 column. 
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Gel Chromatography: 
Gel Chromatography was performed on a Sephadex G-200 
column (86.0x2.25 cm). In one litre of water nearly 10.0 
gram of sephadex G-200 was suspended. The complete swelling 
was achieved by keeping the gel in a water bath at 100°C for 
five hours, then the fine particles in the gel were removed 
by washing the gel several times with water. 
A' column of uniform diameter was thoroughly cleaned 
with detergent, chromic acid and finally with water and 
mounted vertically in a stand with the help of clamp. The 
outlet of the column was connected with a small latex tubing 
attached with a screw stopcock to regulate the flow rate. 
The radius (r) of the column was determined by measuring the 
volume (v) of a certain height (h) of liquid column at two 
different places. The relation used for the determination of 
radius (r) of column is 
V =7Tr2h ^^ ^ 
^1 = n— 
Clean and boiled glass wool was placed at the bottom end of 
the column. The surface of glass wool was covered with a 
layer of glass beads. One third of the column was then 
filled with the operating buffer, then whole gel slurry was 
poured into the column with the help of a glass rod. The gel 
was left to settle under gravity over night at room 
temperature. The outlet was opened carefully at a flow rate 
18 
of 5.0 ml per hour when the gel formed a smooth surface. The 
flow rate was increased gradually to a value approximately 
1.5 times of the desired flow rate, as the gel settled down. 
The gel bed was stabilized by passing 0.06 M sodium 
phosphate buffer, pH 7.0 containing 0.02% sodium azide, 
which was three times of the total bed volume. By passing a 
band of Q.2% blue dextran 2000, the packing of the column 
was checked and the void volume (Vo) was obtained by elution 
profile of blue dextran. In the same manner a column 
(44.5 x 1.76 cm) was packed with Sephacryl S-300. This 
column was used for analytical purposes. 
For application of sample on a column the eluant 
buffer was first drained off before the application of 
sample on the column. The sample was applied carefully with 
the help of an applicator. The sample size usually being 1.0 
to 1.5 7o of the total volume of the column. The stopcock was 
then opened slowly and the sample was allowed to pass down 
the upper gel surface. When all the protein solution had 
passed into the gel , an equal volume of buffer was applied 
and allowed to pass through the gel bed. The column was then 
connected with the buffer reservoir and the column flowrate 
was adjusted to the desired flow rate. Fractions of 2.0 to 
5.0 millilitre were collected. The column was monitared by 
the method of Lowry et^ al (1952). 
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Polyacrylamide gel Electrophoresis: 
Polyacrylamide gel electrophoresis was performed in 
tris glycine buffer at pH 8.2 according to the method of 
Davis (1964). The gel tubes (10.0 x 0.4 cm) were washed with 
detergent, chromic acid and then with water before use. The 
tubes were dried and then siliconzed with 57o 
dichlorodimethyl silane solution in chloroform. The tubes 
were then vertically fixed in a stand with their Lower end 
closed with rubber stoppers. Two millilitres of small pore 
solution containing 77o (W/V) acrylamide, 0.187o (W/V) 
- N,N'-methylene bisacrylamide, 0.047, (W/V) N,N,N',N' 
tetramethyl ethylene diamine (TEMED), 0.077o ammonium per 
sulphate, 4.577, (W/V) tris (hydroxyethyl amino methane) were 
added to each gel tube and the surface of the small pore gel 
was covered with a few drops of water. The water was removed 
by strips of filter paper after thirty minutes of 
polymerization at room temperature. Then 0.2 millilitre of 
the large pore solution containing 2.57o (W/V) acrylamide, 
0.6257o (W/V) N,N' methylene bisacrylamide, 0.0627o (V/V) 
TEMED, 0.0057o (W/V) riboflavin, 67. (V/V) 1.0 N hydrochloric 
acid, 0.75% (W/V) TRIS and 0.207, (W/V) sucrose, was pipetted 
in each tube and its surface was covered with few drops of 
water, It was polymerized under fluorescent light for 10-15 
minutes. After photopolymerization the water was removed and 
the surface was rinsed with sample buffer of each gel tube. 
The lower tank of the electrophoresis assembly was filled 
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with buffer and the gel tubes were suspended in such a 
manner that the large pore gel containing end of the tube 
was projecting in the upper chamber of electrophoresis 
assembly. 
25-85 Mg of protein was taken in 0.1 ]\l of buffer 
containing 40.0 mg of sucrose mixed with a drop of 0.017o 
(W/V) bromophenol , blue in sample preparation. Then 0.1 
millilitre of sample was applied in each tube and the 
remaining space filled carefully with tris glycine buffer. 
The upper chamber was also filled with the tris glycine 
buffer so as to dip the tubes completely. Electrophoresis 
was carried out with an anodic current of 4.0-5.0 mA per gel 
tube and it was continued till the bromophenol blue band had 
migrated to about three fourth of the gel length. The gels 
were carefully removed with the help of a long needle 
attached to a syringe after electrophoresis. The gel were 
then stained for half an hour in 17o (W/V) amidoschwarz 
solution in 7% (V/V) acetic acid. Destaining was performed 
mechanically by washing the gels with 7% acetic acid at 37°c. 
The relative mobility was obtained by 
r,^ ^ distance travelled by protein 
distance travelled by dye 
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Interaction of bilirubin with albumins: 
Bilirubin solution was prepared by dissolving 6.0 mg 
bilirubin crystals in 1.0 ml of 1.0 M sodium carbonate 
solution containing 1.0 m M EDTA and the volume was made 
upto 10.0 ml with 0.1 M tris HCl buffer, pH 8.0, 1=0.15. The 
biliribin solution was filtered through a millipore filter 
and stored at 4°e. To protect the solution from 
photo iso, merization the bottle was wrapped with a black 
carbon paper. The determination of bilirubin concentration 
was done spectrophotometrically by using molar absorptivity 
of 47,500 at 440 nm (Jacobsen.. and Wennberg, 1974). 
An Absorption spectra of free bilirubin and complexes 
of bilirubin with albumins (BSA^HSA and SSA) were recorded 
at room temperature in the wavelength range 550-360 nm. The 
complexes of bilirubin and albumin were prepared in molar 
ratios of 0.5, 1.0 and 2.0. For each molar ratio a separate 
blank was prepared which contained identical amount of 
bilirubin but no protein. 
The interaction of bilirubin with albumin at 
different ionic strength was studied at pH 8.0 and at 
bilirubin albumin molar ratio of 1.0. At all the ionic 
strengths - 0.024 M sodium phosphate buffer was used. The 
desired ionic strength was achieved by adding requisite 
amount of sodium chloride. Respective blanks were prepared 
in the same way except that they were devoid of protein. 
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Absorption spectra and different absorption spectra were 
obtained as described above. 
The interaction of bilirubin with albumins at 
different pH values was studied by visible absorption 
spectroscopy by using bilirubin-albumin molar ratio of 1.0. 
In test tubes bilirubin and albumin were taken in equimolar 
amount to obtain a molar ratio of one and buffer of 
different pH was added. Absorption spectra of 
bilirubin-albumin complexes were recorded in the wavelength 
range of 550 to 360 nm. Respective blanks were prepared in 
the same manner except that they were devoid of protein. 
Difference absorption spectra were obtained as described 
above. 
Fluorescence measurements: 
a) Fluorescence excitation and emission spectra: 
Fluorescence emission and excitation spectra were 
obtained in 0.1 M tris HCI buffer, pH 8.0. An excitation 
wavelength of 282 nm was fixed for recording the emission 
spectra of all the three preparations. 
The excitation spectra were obtained by fixing the 
emission wavelength at'•336nm5.328nm and 338 nm for BSA, HSA and 
SSA respectively. Following settings were used during 
fluorescence measurements: 
Abscissa scale X4 
Ordinate Scale X8 
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Scan speed Very fast 
Sensitivity a) low for measuring excitation 
and emission spectra 
b) High for fluorescence 
quenching studies. 
Emission slit 10 nm 
Excitation slit 10 nm 
Emission startwavelength 300 nm 
Emission end wavelength 400 nm 
Excitation start Wavelength 250 nm 
Excitation end Wavelength 320 nm 
b) Fluorescence quenching studies: 
Fluorescence quench titration were carried out in 
tris HCl buffer, pH 8.0, 1=0.10 at 25°C- A protein 
concentration of 5.0 yUM was fixed for all the three 
preparations. Increasing amounts of bilirubin were added in 
order to obtain a varying molar ratios from 0.0 to 2.0 
between bilirubin and albumin. All - the three protein 
preparations were excited at 282 nm and emission spectra 
were recorded in the wavelength range of 300-400 nm. 
Fluorescence intensity obtained in the presence of bilirubin 
was converted into relative fluorescence by taking the 
fluorescence intensity in the absence of bilirubin as 100. 
Finally percent fluorescence quenching was calculated and it 
was ploted against bilirubin albumin molar ratio. 
R E S U L T S 
A N D 
D I S C U S S I O N 
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RESULTS AND DISCUSSION 
In these studies serum albumin from three different 
animal species namely bovine, human and sheep have been 
used. While bovine serum albumin was obtained from 
commercial sources (Sigma Chemical Co.), human and sheep 
serum albumins were isolated from the human and sheep sera 
respectively by a salt fractionation procedure developed in 
this laboratory (Tayyab and Qasim, 1990). Fresh sheep blood 
was obtained from the animal house wherease outdated human 
blood was obtained from the blood bank of J.N. Medical 
College. 
The elution profiles of sheep and human serum 
albumins isolated by the procedure described in the 
experimental section are shown in Fig. 2. The elution 
profile of commercial bovine serum albumin is given in 
Fig. 3. A fair degree of size homogeneity appeared in all 
these preparations. The fast eluting small peaks in bovine 
serum albumin probably result from the presence of various 
aggregated form of albumins. Such aggregated forms were 
absent from HSA and SSA preparations. The elution volume 
(Ve) to void volume (Vo) ratio of the major .peaks in all 
three preparations was identical within experimental error 
(See Table IV. ). 
Fig. 2- Elution profiles o£ HSA (a) and SSA (b) on 
Sephacryl S-300 column (44.0x1.76 cm). Ten 
milligrams of protein in 1.0 ml buffer was 
applied and the column was operated at a flow 
rate of 15 ml/hour.. Sodium phosphate buffer, 
pH 7.0 I = 0.15, was used as eluant. The 
fractions of 1.0 ml were collected and 
monitored by the method of Lowry. e^ al • 
(1951) .-
UJUOOZ iD e o u D q j o s q v 
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Fig. 3- Elution profile of BSA on Sephacryl S-300 column 
(44x1.76 cm). Ten milligrams of protein in 1.0 
ml buffer was .applied and the column was 
operated at a flow rate of 15 ml/hr. Sodium 
phosphate buffer, pH 7.0, I = 0.15 was used as 
eluant. The fractions of 1.0 ml were collected 
and monitored by the method of Lowry et^  al 
(1951). 
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TABLE - IV 
Gel Filteration, electrophoresis and fluorescence data for 
serum albumins. 
Albumin Preparations Ve/Vo Rm. Excitation Emission 
maximum(nm) maximum(nm) 
Bovine serum albumin 1.81 0.870 282 336 
Human serum albumin 1.83 0.862 282 329 
Sheep serum albumin 1.83 0.779 282 338 
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The charge homogeneity in various albumin 
preparations was checked by polyacrylamide gel 
electrophoresis performed in 0.02 M Tris-glycine buffer, pH 
8.2. The electrophoretic pattern is shown in Fig. 4 . In 
each albumin preparation only one major band was obtained 
indicating that the preparation was homogeneous with respect 
to charge. The relative mobility values of protein bands are 
depicted in Table IV. , 
Fluorescence excitations and emission spectra of BSA, 
HSA and SSA are shown in Figs. 5-6. All the three proteins 
gave an excitation maximum at 282 nm and emission maximum 
between 330 and 338 nm. 
The results are depicted in Table IV.. Occurance of 
emission maximum between 330 and 340 nm is consistent with 
the presence of tryptophan residues in these preparations. 
HSA and BSA contain one and two tryptophan and 18 and 20 
tyrosine residues respectively. The amino acid composition 
of SSA is not known, however, from its fluoresence emission 
spectrum it is clear that it also contains atleast one 
tryptophan. 
The visible absorption spectra of bilirubin and 
bilirubin-albumin complexes are shown in Fig. 7. , The 
absorption maximum of aqueous bilirubin solutions occured at 
435 nm. There was a red shift .^  , of about 25 nm 
in the absorption spectrum of bilirubin by the addition of 
equimolar amount of an albumin preparation as shown in Fig.7. 
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F i g . 4 - Polyacryl amide g.ei elex:uTqfihret'ic .patterTi (.of 
BSA, HSA :cind SSA iperformed ' in '0;02 M ^tnris -
g lyc ine buffer,, pH '8 .2 . .A c u r r e n t of 4 mA/^gcl 
tube was appl ied for 4 •houfs. 'The '.gels >v?ere 
s t a ined with 17c. amidoschwarz 'and des ta i 'ned 
Biechanically —^i^h ^ ^ ^ace t i^s—-^e i^ iVar^lous 
p r o t e i n hands are BSA ( 1 ) , HSA (2) and SSA ( 3 ) . 
The arrow shows t h e p o s i t i o n s of dye 'bands. 
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Fig. 5- Flourescence excitation spectra of BSA (A) , HSA (B) 
and SSA (C) in 0.1 M tris HCl buffer, pH 8.0. 
The excitation spectra were recorded at an 
emission wave length of 336 nm. 
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Fig. 6- Fluorescence emission spectra of BSA (A)jHSA (B) 
and SSA (C) in 0.1 M tris HCl buffer, pH 8.0. 
The emission spectra were recorded at excitation 
wavelength of 282 nm. 
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Fig. 7- Absorption spectra of bilirubin in absence (O) 
and the presence of BSA(«), HSA (©) and SSA (A). 
These spectra were obtained in 0.1 M tris HCl 
buffer, pH 8.0, I = 0.15. Molar ratios of 
bilirubin over albumin were 1.18 in BSA and HSA 
and 1.02 in SSA. The protein concentration was 
8-15 uM. 
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The interaction of bilirubin with albumins (BSA, HSA 
and SSA) was studied at different molar ratios of bilirubin 
to albumin viz. 0.5, 1.0 and 2.0. The visible difference 
spectra of complexes of bilirubin with BSA, HSA and SSA 
obtained at pH 8.0, 1=0.15 are shown in Figs. 8—10. The 
difference spectra were recorded by measuring absorbance of 
bilirubin-albumin complexes using bilirubin solutions of 
identical concentration as blank. The bilirubin binding was 
expressed in terms of difference spectral change at 480 nm 
(A0D-^ '^ ° at 480 nm). The results are shown in Table V. 
In view of the proposed importance of salt bridge in 
bilirubin-HSA and bilirubin-BSA interaction, the effect of 
ionic strength on the interaction of bilirubin with all the 
three albumin preparations was studied. The influence of 
ionic strngth on bilirubin-albumin interaction was studied 
by visible absorption spectroscopy. The bilirubin-albumin 
difference spectra for the three albumin preparations at 
bilirubin/albumin molar ratio 1.0 and at five different 
ionic strengths are shown in Figs. 11-13. Fig. 14 shows a 
plot of difference in absorption at 480 nm versus ionic 
strength for BSA, HSA and SSA. It pan be seen from Figs. 11 
to 13 as well as from Fig. 14 that jthe difference spectral 
change at 480 nm decreases with increase in the ionic 
strength. This decrease in difference spectral change at 480 
nm with increase in ionic strength clearly suggests 
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Visible difference absorption spectra of 
bilirubin-BSA complex obtained in 0.1 M tris HCl 
buffer, pH 8.0, I = 0.15 at different molar 
ratios of bilirubin over albumin. The molar 
ratios were 0.5 (O), 1.0 (A) and 2.0 (•). The 
protein concentration was 6 .0 pM. 
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Fig. 9- Visible difference absorption spectra of 
bilirubin - HSA complex obtained in 0.1 M tris 
HCl buffer, pH 8.0 I = 15 in different molar 
ratios of bilirubin over albumin. The molar 
ratios were 0.5 (O), 1.0 (^ ) and 2.0 (•). The 
protein concentration was 1.0 pM. 
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Fig. 10- Visible difference absorption spectra of 
bilirubin-SSA complex obtained in 0.1 M tris HCl 
buffer, pH 8.0 I = 0.15 in different molar 
ratios of bilirubin over albumin. The molar 
ratio was 0.5 (O), 1.0 (A) and 2.0 (•). The 
protein concentration was 8.0 pM. 
37 
TABLE - V 
Comparative bilirubin binding data of serum albumins at 
different molar ratios (0.5, 1.0, 2.0) 
Molar ratio 
(B/A) 
Z^ OD^ °^ at 480 nm 
BSA HSA SSA 
0.5 1.431 0.998 2.20 
1.0 2.109 1.996 3.69 
2.0 3.370 4.105 4.25 
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Fig. 11- Visible difference absorption spectra of 
bilirubin-BSA complex obtained at different 
ionic strengths. The representation of different 
ionic strengths are 0.02 (O), 0.05 (A), 0.2 (A), 
0.5 (•) and 1.0 (*). The molar ratio of 
bilirubin over albumin was 1.0. The spectra were 
recorded in 0.1 M HCl buffer, pH 8.0. The ionic 
strengths were adjusted with sodium chloride. 
The protein concentration was 12.0 )iM. 
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Fig. 12- Visible • difference absorption spectra of 
• bilirubin-HSA complex obtained at different 
ionic strengths. The representation of different 
ionic sti^ engths are 0.02 (O) ,0.05. (A) , 0-.2 ( A ) , 
0.5 ( • ) :, and 1.0 (^ ) . The molar ratio of 
bilirubin over albumin was' 1.0. The spectra were 
recorded in 0.1 M tris HCl buffer, 8 :t). The 
ionic strengths were . adjustejd with sodium 
chloride. The-protein 'fcoricentration was 8.0 pM. 
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Fig. 13- Visible difference absorption spectra of 
bilirubin-SSA complex obtained at different 
ionic strengths. The representation of different 
ionic strengths are 0.02 (O), 0.05 {^), 0.2 (•) , 
,0.5 i^) and 1.0C*)The molar ratio of bilirubin 
over albumin was 1.0. The spectrai were recorded 
in 0.1 M tris HCl buf f er-,! pH i^ Jo ithe ionic 
strengths were :adjusted with'•'Sodium chloride and 
the protein concentration was 15.0 pM. 
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Fig, 14- Plot of AOD^^^gQ ^^ of b i l i r u b i n - a l b u m i n 
complexes as a f u n c t i o n of i o n i c s t r e n g t h s . (O) , 
( • ) , ( A ) r e p r e s e n t BSA, SSA and HSA 
r e s p e c t i v e l y . 
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importance of electrostatic interaction in bilirubin-albumin 
interaction. The effect was more pronounced in BSA and SSA 
than in HSA (see Table VI). This presumably means that 
electrostatic interaction between the carboxylate anions of 
bilirubin and positively charged groups contributed by Lys 
(or Arg) in the protein make greater contribution in this 
interaction in the former two albumins than in the latter 
albumin. The primary structure of HSA' and BSA from residue 
210 to 240 is shown in Fig. 15. This region is believed to 
contain the Lysine residue (Lys 238 in BSA and 240 in HSA) 
involved in salt bridge formation with the carboxylate 
groups of bilirubin. It can be seen that this region is 
highly conserved in BSA and HSA. 
The effect of pH on the interaction of bilirubin with 
all the three preparations was studied by visible absorption 
spectroscopy. The bilirubin-albumin difference spectra for 
the three albumin preparations at bilirubin/albumin molar 
ratio of 1.0 and at seven different pH are shown in 
Figs. 16-18. Fig. 19 shows plot of pH versus ^00''-'^° at 480 nm. 
It can be seen that in all the three preparations pH has no 
effect on bilirubin-albumin interaction between pH 8.0 and 
pH 11.0 Beyond pH 11.0 bilirubin-albumin interaction shows 
a sharp decrease. This decrease is presumably because of 
alkaline denaturation of albumin. The effect of pH on 
bilirubin-albumin interaction once again emphasizes that if 
a lysine residue is involved in this interaction then it 
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TABLE - VI 
Comparative bilirubin binding data of serum albumins 
at different ionic strengths (0.02 to 1.0) 
17 Serum albumin Ionic strength ^OD at 480 nm 
Bovine serum albumin 0.02 3.516 
0.05 3.256 
0.20 3.004 
0.50 2.367 
1.00 1.913 
Human serum albumin 0.02 1.748 
0.05 1.642 
0.20 1.613 
0.50 1.661 
1.00 1.613 
Sheep serum albumin 0.02 3.845 
0 . 0 5 3 .942 
0 . 2 0 3 .468 
0 . 5 0 3 .314 
l.-OO 2 .927 
Fig. 15- Amino acid sequence (210-240) of primary 
bilirubin binding site of HSA ( A1 (Meloun 
e^ a_l, 1975) and BSA (B) (Brown and schokley, 
1982). 
A 
,24^ 240 
232 230 
^ V o i 
222 220 
^ 
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212 210 
Fig. 16- Visible differeirce absorption spectra of 
bilirubin-BSA complex obtained at different pH 
values. The representation of different pH 
values are-pH 8.6,(O), pH 9.0 (O), pH 10.0 (A) 
pH 10.5 /(i»), pH 11.0 (A), pH 11.5 (^ ) and pH 
12.0 (X);.'; The spectra were obtained in 0.1 M 
tris""' HCi buffer, pH " B'.O. The protein 
concentration was 10.0 pM and the molar ratio of 
bilirubin over albumin was 1.0. 
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Fig. 17-; Visible difference absorption. spectra of 
' •' bilirubinrHSA complex obtained at different pH 
values. .-xTh^ -.pj,^ ^^  of different pH values 
are ;pH 8.0(0), ^ p^H 9 .0 ( © );, pH . 10.0 (© ) , pH 
10.5 (A),';.pH 11.0 (A), pH 11.5 (^ ) and pH 
12.0 (X). The spectra were, obtained in 0.1 M 
tris HCl buffer, pH ';^8.0. ; The protein 
concentration'.was 8.0 pM.and the; molar ratio of 
bilirubin oveirr'a^ lbumin >ias' 1.0. 
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Fio. 18- Visible difference absorption; spectra of 
.bilirubin SSA complex obtained at different pH 
values, The representation of different pH 
values are pH 8.0 {©), pH 9.0 (O), pH 10.0 (O) , 
pH'lO.S (A), pH 11.0 (>^ )V pH 11.5 (A'), and 
pH 12.0 (X). The spectra were obtained in 0.1 M 
tris HCl buffer, pH 8.0. The protein 
concentration was 7.0 pM and the:molar ratio of 
bilirubin over albumin was 1.0. 
+ 0.30 
+ 0.20 -
o 
c 
o 
JO 
o 
< 
+ 0.10 -
0.00 
- O J O -
- 0.15 -
360 440 
Wavelength ( n m ) 
520 
48 
£ 
c 
Q 
CO 
q 
d 
< 
Fig. 19- Plot of A OII^\QQ of bilirubin-albumin 
complexes as a function of pH values. (O), (•), 
(A) represent BSA, SSA and HSA respectively. 
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must have an abnormally high pK value presumably greater 
than 11.0. This explanation fits nicely into earlier 
finding which have indicated that the critical lysine 
residue is hurried in the protein interior (Tayyab and 
Qasim, 1987; Mir et al, 1992). 
Fluorescence quench titration of albumins with 
bilirubin was performed by taking a fixed concentration of 
protein in different test tubes. Increasing amount of 
bilirubin was added to obtain a molar ratio of 0.2 to 2.0 
between bilirubin and albumins. The representative 
fluorescence emission spectra of all the three preparations 
obtained at ionic strength 0.15 and at different molar 
ratios is shown in Fig. 20. Figs 21 to 23 show plots of 
fluorescence pGYcent quenching versus bilirubin-albumin 
molar ratios. The results are given in Table VII. In all 
three albumins the extent of quenching at a given bilirubin/ 
albumin ratio was within experimental error indentical to 
each other. From all the results of bilirubin-albumin 
interacxtion described above, it appears that the mechanism 
of interaction of bilirubin with sheep serum albumin is 
similar to those of bilirubin BSA and bilirubin-HSA 
interaction. 
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Fig. 20- Emission spectra of BSA (A), HSA (B) and SSA (C) 
obtained in absence (1) and presence (2 to 8) of 
bilirubin in 0.1 M tris HCl buffer, pH 8.2. The 
molar ratios of bilirubin to albumin were 
(from top to bottom) 0,0.2, 0.4, 0.6, 0.8, 1.0, 
1.5 and 2.0. The excitation wavelength was 282 
nm. The protein concentration was 5.0 pM. 
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Fig. 21- Plot of percent quenching of BSA as a function 
of bilirubin -albumin ratio.. The spectra were 
obtained in 0.1 M tris HCl buffer, pH 8.0. The 
protein concentration was 10.0 ;JM. 
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Fig. 22- Plot of percent quenching of HSA as a function 
of bilirubin-albumin ratio. The spectra were 
obtained in 0.1 M tris HCl buffer, pH 8.0. The 
protein concentration was 10.0 pM. 
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Fig. 23- Plot of percent quenching of SSA as a function 
of bi l i rubin-albumin r a t i o . The spectra were 
obtained in 0.1 M t r i s HCl buffer , pH 8.0. The 
protein concentrat ion was 10.0 pM. 
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TABLE - VII 
Comparative fluorescence quenching data of BSA, HSA and SSA 
Serum albumins B/A ratio Relative °L Quenching 
fluorescence 
BSA 
HSA 
SSA 
0.02 
0.20 
0.40 
0.60 
0.80 
1.0 
1.5 
2.0 
0.0 
0.20 
0.40 
0.60 
0.80 
1.0 
1.5 
2.0 
0.00 
0.20 
0.40 
0.60 
0.80 
1.0 
1.5 
2.0 
100.00 
86.095 
74.665 
56.385 
43.809 
32.380 
20.950 
17.523 
100.00 
84.80 
68.80 
60.00 
50.56 
41.92 
29.60 
24.80 
100.00 
89.947 
77.998 
67.686 
62.398 
50.500 
32.785 
23.663 
0.0 
13.905 
25.334 
43.620 
56.191 
67.191 
79.050 
82.477 
0.00 
15.20 
31.20 
40.00 
49.44 
58.08 
70.40 
75.20 
0.00 
10.002 
22.002 
32.314 
37.602 
49.500 
67.23 4 
76.334 
R E F E R E N C E S 
55 
REFERENCES 
Adams, P.A. and Berman, M.C. (1980). Biochem. J. 19J^ , 95-102. 
Anderson, S.R. and Weber, G. (1969). Biochemistry 8^ , 371-377. 
Baldwin, R.L. (1957). Biochem. J. 6^,503-512. 
Bjerrum, O.J. (1968). Scand. J. Clin. Lab. Invest. 22, 41-48. 
Brodersen, R. (1974). J. Clin. Invest. _54, 1353-1354. 
Brodersen, R. (1978). In "Intensive care in the Newborn" 
(L. Stern, W. Oh. and B. Friss-Hansen, eds. ) . Vol. 
2, pp. 331-345 Masson, New York. 
Brodersen, R. (1979). CRC Crit. Rev. Clin. Lab. Sci. 11, 
305-399. 
Brodersen, R. and Ebbessen, F. (1983). J. Pharm, Sci. 72, 
248-253. 
Brown, J.R. (1976). Fed. Proc. Fed. Am. Soc. Exp. Bio. 
35, 2141-2144. 
Brown, J.R. (1978). In "Albumin structure. Biosynthesis, 
Function" (T. Peters, and T. Sjoholm, eds) pp 1-10, 
Pergamon press, Oxford. 
Brown, J.R. and Schokley, P. (1982). In "Lipid-protein 
Interaction" (P. Jost and O.H. Griffith, eds) Vol. 
1, pp 25-68. 
Burkhard,R.K. Moore F.A. and Louloudes, S.J. (1961) Arch. 
Biochem. Biophys. 94, 291-300. 
Charlwood, P.A. (1961). Biochem. J. 78, 163-172. 
Cunningham, V.J., Hay, L. and Stoner, H.B. (1975). Biochem. 
J. 146, 653-658. 
56 
Dugaiczyk. A., Law S.W. and Dennison, O.E. (1982). Proc. 
Natl. Acad. Sci. USA, 7^, 71-75. 
Edwards P.B., Rombauer, R.B., and Campbell, B.J. (1969). 
Biochim. Biophys. Acta. 194, 234-245. 
Fogh - Anderson, N. (1977). Clin. Chem. 2^, 2122-2126. 
Folin, 0. and Ciocalteu, V. (1927) J. Biol. Chem. 73^ , 627-650, 
Fuller, R.W. and Roush, B.W. (1973). Biochem. Physiol (B) 
46, 273-276. 
Ghiggeri,G. and Queirolo, C.(1985). Clin.Chim.Acta 145, 
205-211. 
Hughes, W.L. (1954). In "The Proteins" (H. Neurath and K. 
Bailey, eds). Vol. II Part B, pp 663-755, Academic 
Press , New York. 
Jacobsen, C. (1972). Eur. J. Biochem. 2^, 513-519. 
Jacobsen, C. (1976). Int. J. Pept. Protein Res. 8, 295-303. 
Jacobsen C. (1978). Biochem. J. 1^, 453-459. 
Jacobsen, J. and Wennberg, R.P. (1974) Clin. Chem, 20, 
783-789. 
Janatova, J. Fuller, J.K. and Hunter, M.J. (1968), J. Biol. 
Chem. 2^, 3612-3622. 
Lau, S.J. and Sarkar, B. (1971). J. Biol. Chem. 296, 
3938-3943. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, 
R.J. (1951). J. Biol. Chem. 19^, 265-275. 
McMillan, D.E. (1974). Biopolymers, 1^, 1367-1376. 
•••y*'' 
^\V' k*^'' 
i ^5 2-^ -^ ,^, 
57 
Biochim. Mir, M.M. Fazili, K.M. and Qa^ ijflV ,M.A. (199; 
Biophys. Acta. 1119, 261-267. 
Peters, T.Jr. (1970). Adv. Clin. Chem. 13, 37-111. 
Peters, T. Jr. (1975). In "The Plasma Proteins" (F.W. Putnam, 
ed.) Vol. 1, pp. 133-181. Academic Press, New York. 
Peters, T. Jr. (1985) Adv. Protein Chem. ^ , 161-245. 
Reed, R.G. (1986). J. Biol. Chem. 2 ^ , 15619-15624. 
Roda, A. Cappelleri, G., Aldini, R., Roda, E., and Barbara, 
L. (1982). J. Lipid Res. 23, 490-495. 
Rodkey, F.L. (1961). Arch. Biochem. Biophys. ^ , 526-531. 
Rodkey, F.L. (1964). Arch. Biochem. Biophys. 108, 510-513. 
Sjoholm. I and Ljungstedt, I. (1973). J. Biol. Chem. 248, 
8434-8441. 
Sollene, N.P., Wu, H.I. and Means, G.F. (1981) Arch. Biochem. 
Biophys. 207^ , 264-269. 
Spector, A.A. and Fletcher, J.E. (1978). In "Disturbances 
in lipid and Lipoprotein Metabolism" pp. 229-248, 
Amer. Physiol. Soc. Rockville, Maryland. 
Squire, P.G. Moser. P. and 0' Konski, C.T. (1968). 
Biochemistry.2, 4261-4271. 
Steiner, J.M. and Edner, O.J. and Bargoot, F.G. (1968). 
Science 162^ , 909-911. 
-Tanford, C. (1968). Adv. Protein Chem. ^ j 121-282. 
Tayyab. S. and Qasim, M.A. (1990). Biochem. Int. 20, 405-415. 
Wright, A.K. and Thompson, M.R. (1975). Biophys. J. 15, 
137-141. 
Yates, F.E. and Urquhart, J. (1962). Physiol. Rev.42, 359-443 
